1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine CAS 253168-94-4 Purity >98.0% (HPLC) Apremilast Intermediate
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine (CAS: 253168-94-4) with high quality, intermediate of Apremilast (CAS: 608141-41-9). Apremilast is used for the treatment of active psoriatic arthritis (PsA) and moderate to severe chronic plaque psoriasis (PSOR). Ruifu Chemical can provide high-quality Apremilast intermediates and impurities.
Ruifu Chemical can provide worldwide delivery, competitive price, excellent service.
Purchase Apremilast intermediates and impurities or other products, please e-mail: alvin@ruifuchem.com
Chemical Name | 1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine |
Synonyms | 3-Ethoxy-4-Methoxy-alpha-[(Methylsulfonyl)Methyl]-benzenemethanamine; 1-(3-Ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethylamine; 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine; 2-(3-Ethoxy-4-methoxyphenyl)-1-(methylsulfonyl)eth-2-ylamine; Apremilast EP Impurity H |
Stock Status | In Stock, Commercial Production |
CAS Number | 253168-94-4 |
Molecular Formula | C12H19NO4S |
Molecular Weight | 273.35 g/mol |
Melting Point | 119.0 to 123.0℃ |
Density | 1.195±0.06 g/cm3 |
Solubility | Soluble in Methanol (Almost Transparency) |
Storage Temperature | Store Long-Term in a Cool and Dry Place |
COA & MSDS | Available |
Origin of Product | Shanghai, China |
Product Categories |
Apremilast Intermediate |
Brand | Ruifu Chemical |
Items | Specifications | Results |
Appearance | White to Off-White Solid | White Solid |
Melting Point | 119.0~123.0℃ | 120.2℃ |
Loss on Drying | <1.00% | 0.23% |
Purity / Analysis Method | >98.0% (HPLC) | 98.35% |
1H NMR Spectrum | Conforms to Structure | Conforms |
Conclusion | The product has been tested and complies with the given specifications | |
Application | Intermediate of Apremilast (CAS: 608141-41-9) |
Package: Fluorinated bottle, Aluminium foil bag, 25kg/cardboard drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
HS Code | 2934999099 |
1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanamine (CAS: 253168-94-4), intermediate of Apremilast (CAS: 608141-41-9). Apremilast is the first and only oral phosphodiesterase IV (PDE- 4) inhibitor and anti-tumor necrosis factor alpha (TNFa) agent launched in the USA by Celgene for the treatment of active psoriatic arthritis (PsA). Apremilast was also approved for the treatment of moderate to severe plaque psoriasis (PSOR) in the USA. Later, this drug was also approved in the European Union (EU) for both indications.